AstraZeneca Korea gets approval from KFDA over Seroquel XR
Published: 2007-12-12 06:57:00
Updated: 2007-12-12 06:57:00
The Korea Food and Drug Administration has approved AstraZeneca Korea's once-daily Seroquel XR (quetiapine fumarate) extended-release tablets (50mg, 200mg, 300mg, 400mg)for treatment of schizophrenia, a company spokesperson said on December 10.
On May 17, 2007, the U.S. Food and Drug Administr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
